Nanoparticle Protein Coatings Influence Drug Delivery Precision
Researchers have uncovered new insights into how protein coatings affect nanoparticles‘ ability to evade immune detection and reach their intended targets within the body, according to recent findings published in the Proceedings of the National Academy of Sciences. The study from University of Delaware engineers suggests that controlling these protein layers could significantly improve nanomedicine effectiveness while reducing unwanted side effects.
Protein Corona’s Role in Immune Recognition
When nanoparticles enter the bloodstream, they immediately acquire a protein corona that influences how the immune system responds to them. Sources indicate this protein layer can either help nanoparticles avoid detection or make them more visible to immune clearance mechanisms. “Understanding the influence of the protein corona on a nanoparticle’s fate will help us design nanomedicines that more reliably evade immune clearance and deliver therapies precisely,” senior author Emily Day told reporters.
Targeting Rare Blood Stem Cells
The research team focused specifically on nanoparticles designed to reach hematopoietic stem cells, which comprise just 0.01% of bone marrow cells. Analysts suggest this extreme rarity makes them particularly challenging targets for drug delivery. The team developed a novel approach using membrane-wrapped nanoparticles derived from bone marrow cells called megakaryocytes, which reportedly helped guide the particles to their marrow destination.
Experimental Findings Reveal Delivery Advantages
Laboratory and animal experiments demonstrated that membrane-wrapped nanoparticles bound less protein overall compared to unwrapped particles. The report states these particles with sparser protein coronas entered target cells more efficiently and were less likely to be consumed by immune cells. Researchers found this was particularly pronounced when the particles were incubated in human serum, where the classes of proteins that bound to them showed distinct differences.
Key Proteins Identified in Clearance Process
Proteomics analyses revealed that apolipoprotein B was the most abundant protein in the corona, contrary to previous studies that found apolipoprotein E more common in similar nanoparticles. Both proteins reportedly help transport molecules throughout the body but can also act as signals that make nanoparticles easier for clearance cells to spot and remove. The research team used specialized mouse models lacking specific proteins to further investigate individual protein effects.
Balancing Targeted Delivery and Immune Clearance
The findings indicate a delicate balance exists between proteins that help immune clearance and those that assist targeted delivery. According to reports, some proteins like complement component 3 and immunoglobulin G were found to help the immune system clear particles to organs like the liver while simultaneously assisting particle delivery to targeted hematopoietic stem cells in bone marrow. “Finding ways to control the levels of these proteins could help shift the balance toward more precise delivery,” Day suggested.
Future Research Directions
The research team is currently exploring how to adjust protein corona composition by altering membrane wrapping components. Future work will extend to humanized mice with human-like immune systems to better understand nanoparticle behavior in people. These developments in nanomedicine parallel other technological advancements across industries, including organizational changes in tech foundations, new regulatory requirements in government operations, software interface improvements, and infrastructure optimization strategies.
Implications for Medical Treatments
The research, available through the published study, could have significant implications for treatments requiring precise drug delivery, including bone marrow transplant preparation and genetic condition corrections like sickle cell disease. Sources indicate that better understanding of protein corona dynamics may lead to nanomedicines that more reliably reach their targets while minimizing off-target effects and immune reactions.
This article aggregates information from publicly available sources. All trademarks and copyrights belong to their respective owners.